稳定性 comes up often in conversation and rarely with the context attached. Here we lay out the basics in order, then work through the practical considerations.
Last reviewed on 2025-11-12. Where a claim depends on a specific study, the study is described rather than over-claimed.
Tirzepatide is a synthetic peptide built from thirty-nine amino acids. Its sequence is derived from native glucose-dependent insulinotropic polypeptide, or GIP, with several non-natural residues and a fatty diacid side chain attached through a linker. The molecule behaves as a dual agonist at two incretin receptors, GIP and GLP-1, instead of targeting a single receptor. This dual engagement separates it from earlier single-receptor incretin compounds and underpins most of its reported pharmacological activity.
At the receptor level, the compound binds both GIP and GLP-1 receptors and triggers downstream signalling that raises cyclic AMP in target cells. GLP-1 receptor activation is associated with glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. GIP receptor activation contributes effects that are less completely characterised, and how much each receptor adds to the overall clinical response is still an open question. The two pathways appear to interact in a complementary rather than a purely additive way.
An extended fatty diacid moiety promotes binding to serum albumin, which slows renal clearance and extends the circulating half-life to roughly five days. That property supports once-weekly administration and largely explains the dosing interval described in clinical reports. Published data come mainly from large randomised programmes that evaluated glycaemic control and body weight over periods of many months. Long-term outcomes beyond those trial windows, including what happens after treatment stops, remain an active area of investigation.
Tirzepatide is a synthetic peptide of 39 amino acids engineered from the native glucose-dependent insulinotropic polypeptide sequence. Its structure incorporates several non-natural residues and a C-terminal segment derived from glucagon-like peptide-1, together with a C20 fatty diacid moiety attached through a linker. The lipophilic side chain promotes binding to serum albumin, which slows renal clearance after administration. The compound is classified as a dual incretin receptor agonist and is supplied as a lyophilized powder for reconstitution or as a preformulated solution, depending on the presentation.
The peptide activates two G protein-coupled receptors, GIPR and GLP-1R. Binding triggers adenylyl cyclase activity and raises intracellular cyclic AMP in pancreatic beta cells, which potentiates insulin release when glucose is elevated. Signaling in the central nervous system is associated with reduced appetite and lower energy intake, while effects on gastric emptying and glucagon secretion are also reported. Because activity at both receptors is retained, the pharmacological profile is often described as incretin-based rather than selective for a single receptor.
After subcutaneous injection, absorption is gradual, and peak plasma levels are generally reached within one to three days. Albumin binding extends the apparent half-life to roughly five days, which supports a weekly administration schedule. Metabolism proceeds mainly through proteolytic cleavage of the peptide backbone and beta-oxidation of the fatty acid chain, rather than through cytochrome P450 pathways. Eliminated fragments are largely recycled through general protein turnover, and excretion of intact drug in urine is minimal. These properties distinguish the molecule from short-acting incretin mimetics.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C225H348N48O68 | Free base form |
| Molecular mass | Approximately 4813 Da | Calculated from the sequence |
| Amino acid residues | 39 | GIP-derived backbone |
| Receptor targets | GIP and GLP-1 | Dual agonist |
| Circulating half-life | About 5 days | Supports weekly administration |
固体状态的 tirzepatide 通常以冻干粉形式保存，推荐在低温、避光、干燥条件下存放，常见区间为 2 至 8 摄氏度，长期保存可考虑更低温度并避免反复冻融。冻融循环会导致肽链聚集或析出，从而影响后续定量结果。容器密封性与湿度控制同样是稳定性研究中反复强调的因素。
溶解操作一般使用注射用水或适宜的水性缓冲液，必要时加入少量助溶剂以改善溶解速度，但应避免剧烈涡旋振荡，因为剪切力可能促进聚集。配制后的溶液在冷藏条件下的稳定时间通常短于固体形态，具体时限取决于浓度、缓冲体系与容器材质。是否加入防腐成分，则取决于用途是否为多次取样。
Development began in the 2010s, when researchers modified a GIP-based scaffold to add GLP-1 activity and then attached the fatty diacid to lengthen its half-life. Clinical evaluation proceeded through large phase 3 programmes in type 2 diabetes and in obesity, and regulators in the United States cleared the compound for type 2 diabetes in 2022 and for chronic weight management in 2023. Several cardiovascular and metabolic outcome studies are still reporting, so the picture of long-term benefit and risk is incomplete. Approvals in other regions followed on different timelines.
Tirzepatide is a synthetic peptide of 39 amino acids that carries a C20 fatty diacid side chain attached through a linker. Its molecular formula is C225H348N48O68, and its molecular weight is about 4813 daltons. The compound belongs to the incretin mimetic class and is administered by subcutaneous injection. The fatty acid chain promotes binding to serum albumin, which slows renal clearance and extends the circulation time of the molecule. It was identified during screening of sequences derived from glucose-dependent insulinotropic polypeptide.
Tirzepatide activates both the glucose-dependent insulinotropic polypeptide receptor and the glucagon-like peptide-1 receptor, making it a dual agonist rather than a selective agent. Engagement of the GLP-1 receptor is linked to glucose-dependent insulin release, slower gastric emptying, and reduced appetite signalling. The relative contribution of the GIP arm remains an active research question; proposed roles include improved insulin sensitivity and altered adipose tissue handling. Receptor occupancy studies suggest the molecule interacts with both targets at circulating concentrations achieved during therapy.
Truck terminals in proximity to industrial clusters, machinery and manufacturing units, agro-processing zones, and integrated cold-chain storage facilities will be planned to build the export-ready and quick logistics infrastructure. The HHBTMSM Expressway will have a separate provision for the optical fiber connectivity and gas pipelines, turning the greenfield expressway into a 'digital-ready' utility corridor.
Gwen Chambers (Rose Abdoo) is a cancer patient who befriends and advises Kristina when Kristina is diagnosed with cancer. Gwen suffers a relapse of cancer and dies around the end of season 5. Kristina names the school she starts "Chambers Academy" in her honor. Dr. Bedsloe (Kurt Fuller) is the physician who performs Kristina's lumpectomy, recommends chemotherapy, and routinely checks up on her to see if the cancer is progressing or if she is cancer-free. Ruby Rizzoli (Courtney Grosbeck) is Hank Rizzoli's daughter, who is 14 in season 5. Sandy Rizzoli (Betsy Brandt) is Hank Rizzoli's former wife and the mother of Ruby Rizzoli. Oliver Rome (Tyson Ritter) is a musician who works for a fictional label in the show. He has his own band called Ashes of Rome. He is often egotistical and hotheaded. Carl Fletcher (Josh Stamberg) is a tenant in the building where Sarah Braverman lives and works as a super in season 5. Carl and Sarah have a brief relationship. Meredith Peet (Sonya Walger), known simply as "Peet", is the architect who hires Joel and his construction crew in season 5. Ed Brooks (David Denman) is a parent at the school Sydney and Victor Graham attend, who is on the sustainability committee with Julia. Their friendship starts to turn into an emotional affair that starts to get complicated when Ed kisses Julia, causing Joel to leave her. Heather Hall (Jurnee Smollett-Bell) is a smart and feisty up-and-coming political campaign adviser whom Kristina hires to be her campaign manager in season 5. Chad “Berto” Roberto (Nick Krause) is Drew's college roommate in season 5.
== Principle in medical diagnostics == Glycation of proteins is a frequent occurrence, but in the case of hemoglobin, a nonenzymatic condensation reaction occurs between glucose and the N-end of the beta chain. This reaction produces a Schiff base (R−N=CHR', R=beta chain, CHR'=glucose-derived), which is itself converted to 1-deoxyfructose. This second conversion is an example of an Amadori rearrangement. When blood glucose levels are high, glucose molecules attach to the hemoglobin in red blood cells. The longer hyperglycemia occurs in blood, the more glucose binds to hemoglobin in the red blood cells and the higher the glycated hemoglobin. Once a hemoglobin molecule is glycated, it remains that way. A buildup of glycated hemoglobin within the red cell, therefore, reflects the average level of glucose to which the cell has been exposed during its life cycle. Measuring glycated hemoglobin assesses the effectiveness of therapy by monitoring long-term serum glucose regulation. A1c is a weighted average of blood glucose levels during the life of the red blood cells (117 days for men and 106 days in women). Therefore, glucose levels on days nearer to the test contribute substantially more to the level of A1c than the levels on days further from the test. This is also supported by data from clinical practice showing that HbA1c levels improved significantly after 20 days from the start or intensification of glucose-lowering treatment.
Sources: en.wikipedia.org
The wildlife of Brazil comprises all naturally occurring animals, plants, and fungi in the South American country. Home to 60% of the Amazon rainforest, which accounts for approximately one-tenth of all species in the world, Brazil is considered to have the greatest biodiversity of any country on the planet, containing over 70% of all animal and plant species catalogued. Brazil has the most known species of plants (55,000), freshwater fish (3,000) and mammals (over 689). It also ranks third on the list of countries with the most bird species (1,832) and second with the most reptile species (744). The number of fungal species is unknown but is large. Brazil is second only to Indonesia as the country with the most endemic species. Brazil's large territory comprises different ecosystems, such as the Amazon rainforest, recognized as having the greatest biological diversity in the world, with the Atlantic Forest and the Cerrado sustaining the greatest biodiversity. In the south, the Araucaria moist forests grow under temperate conditions. The rich wildlife of Brazil reflects the variety of natural habitats. Scientists estimate that the total number of plant and animal species in Brazil could approach four million, mostly invertebrates. Larger mammals include carnivores pumas, jaguars, ocelots, rare bush dogs, and South American foxes, and herbivores peccaries, tapirs, anteaters, sloths, opossums and armadillos. Deer are plentiful in the south, and many species of New World monkeys are found in the northern rainforests.
=== Civil society === Reactions also came from European civil society organisations. Transparency International described the incident as "the most egregious case" of alleged corruption the European Parliament has ever seen. The founder of the Good Lobby commented that "[w]hatever its final outcome, [the] Qatar 'corruption' scandal has unveiled an inconvenient, and for most Europeans already obvious, truth. Money does buy influence in the EU", and that "[t]he EU Parliament and most of its members have historically resisted stricter integrity rules and [an] effective enforcement system." As news broke of the investigation, the honorary board of the implicated NGO, Fight Impunity, resigned en masse. The board members included high-profile European policymakers including Federica Mogherini (former EU High Representative in the Juncker Commission), Bernard Cazeneuve (formerly Prime Minister of France), Dimitris Avramopoulos (former EU Commissioner for Migration, Home Affairs and Citizenship in the Juncker Commission), Cecilia Wikström (former MEP) and Emma Bonino (former EU Commissioner for Health and Consumer Protection in the Santer Commission). The honorary board has no executive or managerial role, so there is no suspicion or accusations against any member of the board. Visentini originally voluntarily stood down temporarily as president of the International Trade Union Congress but a specially convened Extraordinary Meeting of the General Council voted to suspend him of all of his duties.
However, newer studies have shown that early wound closure and early fixation reduces infection rates, promotes fracture healing and early restoration of function. Therefore, assessment of all open fractures should include the mechanism of injury, the appearance of soft tissues, the likely levels of bacterial contamination and the specific characteristics of the fractures. Accurate assessment of the fracture can only be performed inside an operating theatre. For more comprehensive prognosis purposes other classification systems, such as the Sickness Impact Profile (as a health status measure), Mangled Extremity Severity Score (MESS) and Limb Salvage Index (LSI) (decision to amputate or salvage a limb), have been devised by Dr Shanmuganathan Rajasekaran.
Among the earliest reports of MOF-based catalysis was the cyanosilylation of aldehydes by a 2D MOF (layered square grids) of formula Cd(4,4′-bpy)2(NO3)2. This investigation centered mainly on size- and shape-selective clathration. A second set of examples was based on a two-dimensional, square-grid MOF containing single Pd(II) ions as nodes and 2-hydroxypyrimidinolates as struts. Despite initial coordinative saturation, the palladium centers in this MOF catalyze alcohol oxidation, olefin hydrogenation, and Suzuki C–C coupling. At a minimum, these reactions necessarily entail redox oscillations of the metal nodes between Pd(II) and Pd(0) intermediates accompanying by drastic changes in coordination number, which would certainly lead to destabilization and potential destruction of the original framework if all the Pd centers are catalytically active. The observation of substrate shape- and size-selectivity implies that the catalytic reactions are heterogeneous and are indeed occurring within the MOF. Nevertheless, at least for hydrogenation, it is difficult to rule out the possibility that catalysis is occurring at the surface of MOF-encapsulated palladium clusters/nanoparticles (i.e., partial decomposition sites) or defect sites, rather than at transiently labile, but otherwise intact, single-atom MOF nodes. "Opportunistic" MOF-based catalysis has been described for the cubic compound, MOF-5.
Sources: en.wikipedia.org
It acts as a dual agonist at the GIP receptor and the GLP-1 receptor. This broader targeting profile distinguishes it from selective GLP-1 agonists, which engage only one receptor.
A fatty diacid side chain promotes binding to albumin, which delays clearance from circulation. The half-life of roughly five days makes a weekly schedule practical.
No. It is a synthetic peptide whose backbone is based on the natural incretin hormone GIP. Non-natural residues and the lipid side chain were engineered to improve stability and duration of action.
It is a synthetic linear peptide that acts as a dual agonist at the GIP and GLP-1 receptors. It combines a modified incretin backbone with a fatty diacid side chain that extends its circulation time. It is not a small-molecule drug and is not orally absorbed in its native form.